Posted by The Ingenium Group eyeforpharma Japan 2017 is your chance to take charge of your commercial excellence and explore ways to remodel strategies to ensure success in the changing environment. It is a premier opportunity to get insights from medical experts and key leaders in Pharma. Top speakers: Click for eyeforpharma Japan’s Full Speaker Faculty Order 2017 brochure Why attend
Posted by Len Anderson BY Nanette Byrnes – Senior Editor, Business Reports at MIT Technology Review Deep manufacturing expertise and extensive supply chains give China a lead that will be tough to overcome. During his presidential campaign and since moving to the Oval Office, Donald Trump has spoken a lot about manufacturing in the U.S. and its competition with
Posted by Greg Leviton BY Michael Thomas – ZS.com While the pharmaceutical industry is still just skimming the surface when it comes to developing therapies to address the 7,000-plus known rare diseases, drug development is only half of the battle. Organizations that have successfully gained approval for their therapies in the U.S. and abroad face significant challenges when planning
Posted by Joe Tomlak BY Joy Macknight – TheBanker.com The way goods and services are traded internationally is changing, fuelled by the globalisation and digitalisation of supply and distribution chains. Are free-trade deals still fit for purpose in a hyperconnected world? Joy Macknight investigates. The future of free-trade agreements (FTAs) has been called into question by recent political developments
Posted by Per Knudsen Japan’s pharma market awaits you CPhI Japan is Japan’s most comprehensive pharma event, which brings together more than 19,000 pharma industry professionals from 100+ countries. A wide range of exhibitors from all pharma areas active in Japan as well as free to attend seminars presented by governmental bodies and other important institutions is what you
Posted by Tito Hen BY Chuhan Wang Dr. David Dantes, a retired ER doctor in his 70s, still manages to work 6 hours a day starting at 6:30 am and sees about 20 patients per day. His lifetime of medical experience would be ending if he hadn’t joined a telemedicine platform earlier this year. Meanwhile, after a long day
Posted by The Ingenium Group BY James K. Stoller, Amanda Goodall, Agnes Baker – HARVARD BUSINESS REPORT Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. These challenges require extraordinary leaders. Doctors were once viewed as ill-prepared for leadership roles because their selection and training led
Posted by Len Anderson BY Philippe Virlouvet In my last blog, I explored the growth of smart devices, big data analytics, and the cloud, and what these technologies mean to operational systems such as MES/MOMs. Briefly, I suggested that MOMs will continue to drive operations for several years, but will have to evolve and adapt as edge technology and
Posted by The Ingenium Group BY Eric Sagonowsky – FIERCEPHARMA Associate Editor Among the many meds that’ll lose patent protection in the U.S. this year are 10 drugs that each contribute in a big way for top drugmakers. Eli Lilly, Pfizer, Takeda, Bristol-Myers Squibb and Gilead are each set to hit the patent cliff this year with some of their
Posted by Per Knudsen “Japan is facing the greatest skills shortage in the world. According to a recent OECD report, 81 percent of firms in Japan (with 10 or more employees) encounter difficulty finding qualified employees.” – Per Knudsen BY Rachel Hallett – WORLD ECONOMIC FORUM The future of work is a key discussion point at the World Economic
